| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Chambers Rebecca is a Chief Financial Officer at VERACYTE, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2025 | VCYT Veracyte, Inc. | Chief Financial Officer | Sell | 13,278 | $46.84 | $621,955.21 | -5.6% | -23.5% | - | |
| Nov 5, 2025 | VCYT Veracyte, Inc. | Chief Financial Officer | Sell | 7,000 | $41.00 | $287,000.00 | -5.3% | -18.0% | - | |
| Feb 3, 2025 | VCYT Veracyte, Inc. | Chief Financial Officer | Sell | 527 | $43.85 | $23,108.95 | -0.5% | -30.5% | -16.2% | |
| Dec 3, 2024 | VCYT Veracyte, Inc. | Chief Financial Officer | Sell | 7,000 | $43.23 | $302,621.90 | -5.8% | -23.1% | +9.4% | |
| Nov 12, 2024 | VCYT Veracyte, Inc. | Chief Financial Officer | Sell | 15,275 | $38.34 | $585,663.36 | -10.9% | +9.6% | +10.6% | |
| Jun 24, 2021 | OM Outset Medical, Inc. | Chief Financial Officer | Sale+OE | 16,727 | $50.72 | $848,373.37 | -55.2% | +7.3% | -68.1% | |
| May 25, 2021 | OM Outset Medical, Inc. | Chief Financial Officer | Sale+OE | 16,727 | $45.11 | $754,534.90 | -55.2% | -10.5% | -52.2% | |
| Apr 27, 2021 | OM Outset Medical, Inc. | Chief Financial Officer | Sale+OE | 16,727 | $56.60 | $946,811.86 | -32.1% | -24.5% | -36.8% | |
| Mar 25, 2021 | OM Outset Medical, Inc. | Chief Financial Officer | Sale+OE | 16,727 | $49.94 | $835,317.80 | -29.3% | -0.8% | -19.0% |